Unique biopharmaceutical company with high barrier of entry, high growth expected, take the deal
3SBio is a leading biopharmaceutical company based in China offering products including EPIAO to cure anemia in Chronic Kidney Disease (CKD),...
284 Views
A Leading Chinese Biotech Company, Quality Cornerstones, Take the Deal
3SBio, a leading Chinese biotechnology company, plans to re-list in Hong Kong after de-listing from NASDAQ in 2013. The company's two main...
287 Views
Opening of E-commerce Channel to Change China's Drug Market
Numerous press outlets report that China’s Food & Drug Administration (CFDA) will release regulations permitting online sales of...
352 Views
Introducing Long Term Leaders - Focussed Insights for your Core Holdings
We are pleased to announce the roll out of our latest content vertical: Long Term Leaders. Under this category, we have identified companies that...
309 Views